| A role for glucagon-like peptide-1 in the central regulation of feeding MD Turton, D O'shea, I Gunn, SA Beak, CMB Edwards, K Meeran, SJ Choi, ... Nature 379 (6560), 69-72, 1996 | 2454 | 1996 |
| Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ... The Lancet 393 (10184), 1937-1947, 2019 | 565 | 2019 |
| Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production L Lynch, M Nowak, B Varghese, J Clark, AE Hogan, V Toxavidis, SP Balk, ... Immunity 37 (3), 574-587, 2012 | 554 | 2012 |
| Metabolic reprogramming of natural killer cells in obesity limits antitumor responses X Michelet, L Dyck, A Hogan, RM Loftus, D Duquette, K Wei, S Beyaz, ... Nature immunology 19 (12), 1330-1340, 2018 | 549 | 2018 |
| Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight M Rossi, SJ Choi, D O’shea, T Miyoshi, MA Ghatei, SR Bloom Endocrinology 138 (1), 351-355, 1997 | 541 | 1997 |
| Repeated intracerebroventricular administration of glucagon-like peptide-1-(7–36) amide or exendin-(9–39) alters body weight in the rat K Meeran, D O’Shea, CMB Edwards, MD Turton, MM Heath, I Gunn, ... Endocrinology 140 (1), 244-250, 1999 | 435 | 1999 |
| Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion … TJ Cawood, PJ Hunt, D O'shea, D Cole, S Soule European journal of endocrinology 161 (4), 513-527, 2009 | 418 | 2009 |
| Complications of obesity D Kinlen, D Cody, D O’Shea QJM: An International Journal of Medicine 111 (7), 437-443, 2018 | 378 | 2018 |
| Invariant NKT cells and CD1d+ cells amass in human omentum and are depleted in patients with cancer and obesity L Lynch, D O'Shea, DC Winter, J Geoghegan, DG Doherty, C O'Farrelly European journal of immunology 39 (7), 1893-1901, 2009 | 311 | 2009 |
| Interplay between the immune system and adipose tissue in obesity MA Exley, L Hand, D O'Shea, L Lynch Journal of Endocrinology 223 (2), R41-R48, 2014 | 307 | 2014 |
| Are natural killer cells protecting the metabolically healthy obese patient? LA Lynch, JM O'connell, AK Kwasnik, TJ Cawood, C O'farrelly, DB O'shea Obesity 17 (3), 601-605, 2009 | 288 | 2009 |
| The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity J O'Connell, L Lynch, TJ Cawood, A Kwasnik, N Nolan, J Geoghegan, ... PloS one 5 (4), e9997, 2010 | 283 | 2010 |
| Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link TJ Cawood, P Moriarty, C O’Farrelly, D O’shea The Journal of Clinical Endocrinology & Metabolism 92 (1), 59-64, 2007 | 272 | 2007 |
| Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study K Meeran, D O’Shea, PD Upton, CJ Small, MA Ghatei, PH Byfield, ... The Journal of Clinical Endocrinology & Metabolism 82 (1), 95-100, 1997 | 268 | 1997 |
| Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus AE Hogan, G Gaoatswe, L Lynch, MA Corrigan, C Woods, J O’Connell, ... Diabetologia 57, 781-784, 2014 | 225 | 2014 |
| Adipose type one innate lymphoid cells regulate macrophage homeostasis through targeted cytotoxicity S Boulenouar, X Michelet, D Duquette, D Alvarez, AE Hogan, C Dold, ... Immunity 46 (2), 273-286, 2017 | 205 | 2017 |
| Altered distribution and increased IL-17 production by mucosal-associated invariant T cells in adult and childhood obesity E Carolan, LM Tobin, BA Mangan, M Corrigan, G Gaoatswe, G Byrne, ... The Journal of Immunology 194 (12), 5775-5780, 2015 | 193 | 2015 |
| Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis AE Hogan, AM Tobin, T Ahern, MA Corrigan, G Gaoatswe, R Jackson, ... Diabetologia 54, 2745-2754, 2011 | 192 | 2011 |
| Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke D O'Shea, TJ Cawood, C O'Farrelly, L Lynch PloS one 5 (1), e8660, 2010 | 190 | 2010 |
| iNKT cells induce FGF21 for thermogenesis and are required for maximal weight loss in GLP1 therapy L Lynch, AE Hogan, D Duquette, C Lester, A Banks, K LeClair, DE Cohen, ... Cell metabolism 24 (3), 510-519, 2016 | 188 | 2016 |